Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Some off-label treatments increase hair density, but long-term safety unknown.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Home-use cosmetic laser and light devices show modest results for hair removal and acne treatment, but more research is needed for confirmation.

New, safer treatments for children's hair disorders are needed, and better evaluation methods are recommended.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Some vaccines might rarely cause hair loss, more research is needed.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The meeting concluded with optimism about increasing research and better management of vitiligo.

Eating less and exercising more, with personalized diet plans and realistic goals, can lead to weight loss and better health, but more research is needed for long-term success.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Lamotrigine may cause hair loss, affecting treatment compliance and health.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.